Mosaic Immunoengineering (CPMV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4 | 65 | 156 | 253 | 363 |
| TOTAL | $12 | $79 | $180 | $286 | $369 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $12 | $79 | $180 | $286 | $369 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 56 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 125 | 130 | 119 | 116 | 131 |
| Accrued Expenses | 4,924 | 4,767 | 4,615 | 4,453 | 4,215 |
| TOTAL | $5,105 | $4,896 | $4,733 | $4,569 | $4,347 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,356 | 1,337 | 1,318 | 1,298 | 1,276 |
| TOTAL | $1,356 | $1,337 | $1,318 | $1,298 | $1,276 |
| Total Liabilities | $6,461 | $6,234 | $6,051 | $5,867 | $5,623 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,242 | 7,242 | 7,242 | 7,242 | 7,242 |
| Retained earnings | -8,499 | -8,205 | -7,916 | -7,621 | -7,288 |
| TOTAL | $-6,448 | $-6,155 | $-5,871 | $-5,581 | $-5,253 |
| Total Liabilities And Equity | $12 | $79 | $180 | $286 | $369 |